Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

NCT00563173 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus Infection

Interventions

DRUG: CHRONVAC-C®

Sponsor

Tripep AB

Collaborators

[object Object]